Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 729-736

  Ledbetter, Eric C ^a   Mun, James J ^b   Kowbel, David ^b   Fleiszig, Suzanne M J ^b  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL DEATH; CELL INVASION; CELL SURVIVAL; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOTOXICITY; ENDOPHTHALMITIS; EPITHELIUM CELL; EXPERIMENTAL DOG; EYE INFECTION; GENOTYPE; KERATITIS; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; ANIMAL; ANIMAL DISEASE; BACTERIAL EYE INFECTION; CORNEA ULCER; DOG; DOG DISEASE; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; CONJUNCTIVITIS, BACTERIAL; CORNEAL ULCER; DOG DISEASES; DOGS; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; GENOTYPE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 59449107602     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2358     Document Type: Article

References (58)

1. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2000;2(9):1051-1060.
2. Hazlett HD, Moon MM, Singh A, Berk RS, Rudner XL. Analysis of adhesion, piliation, protease production and ocular infectivity of several P. aeruginosa strains. Curr Eye Res. 1991;10(4)351-362.
3. Hobden JA. Pseudomonas aeruginosa proteases and corneal virulence. DNA Cell Biol. 2002;21(5-6):391-396.
4. Pillar CM, Hobden JA. Pseudomonas aeruginosa exotoxin A and keratitis in mice. Invest Ophthalmol Vis Sci. 2002;43(5):1437-1444.
5. Fleiszig SM, Evans DJ. The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa. Clin Exp Optom. 2002; 85(5):271-278.
6. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107(8):1497-1502.
7. Farrell PL, Smith RE. Bacterial corneoscleritis complicating pterygium excision. Am J Ophthalmol. 1989;107(5):515-517.
8. Celik I, Cihangiroglu M, Yilmaz T, Kohle U, Akbulut A. The prevalence of bacteraemia-related retinal lesions in seriously ill patients. J Infect. 2006;52(2):97-104.
9. Eifrig CW, Scott IU, Flynn HW Jr., Miller D. Endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology. 2003; 110(9):1714-1717.
10. Suneetha N, Battu RR, Thomas RK, Bosco A. Orbital abscess: management and outcome. Indian J Ophthalmol. 2000;48(2): 129-134.
11. Van Horn DL, Davis SD, Hyndiuk RA, Pederson JH. Experimental Pseudomonas keratitis in the rabbit: bacteriologic, clinical, and microscopic observations. Invest Ophthalmol Vis Sci. 1981;20(2): 213-221.
12. Wyman M, Swanson C, Kowalski JJ, Powers JD, Boraski EA. Experimental Pseudomonas aeruginosa ulcerative keratitis model in the dog. Am J Vet Res. 1983;44(6):1135-1140.
13. Fleiszig SM, Zaidi TS, Fetcher EL, Preston MJ, Pier GB. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun. 1994;62(8):3485-3493.
14. Fleiszig SM, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun. 1995;63(10):4072- 4077.
15. Apodaca G, Bomsel M, Lindstedt R, et al. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun. 1995;63(4):1541-1551.
16. Fleiszig SM, Zaidi TS, Preston MJ, Grout M, Evans DJ, Pier GB. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect and Immun. 1996;64(6):2288-2294.
17. Cole N, Willcox MD, Fleiszig SM, et al. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res. 1998;7(7):730 -735.
18. Fleiszig SM, Weiner-Kronish JP, Miyazaki H, et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infec Immun. 1997;65(2):579 -586.
19. Evans DJ, Frank DW, Finck-Barbancon V, Wu C, Fleiszig SM. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity. Infect Immun. 1998;66(4)1453-1459.
20. Finck-Barbancon V, Goranson J, Zhu L, et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol. 1997;25(3):547-557.
21. Hauser AR, Fleiszig SM, Kang PJ, Mostov K, Engel JN. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells. Infect Immun. 1998;66(4):1413-1420.
22. Cowell BA, Chen DY, Frank DW, Vallis AJ, Fleiszig SM. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells. Infect Immun. 2000;68(1):403- 406.
23. Lee EJ, Cowell BA, Evans DJ, Fleiszig SM. Contribution of ExsAregulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest Ophthalmol Vis Sci. 2003;44(9):3892-3898.
24. Brockman EB, Tarantino PA, Hobden JA, et al. Keratotomy model of Pseudomonas keratitis: gentamicin chemotherapy. Refract Corneal Surg. 1992;8(1):39-43.
25. Mah FS, Romanowski EG, Kowalski RP, Yates KA, Gordon YJ. Zymar (Gatifloxacin 0.3%) shows excellent gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model. Cornea. 1997;26(5): 585-588.
26. Alionte LG, Cannon BM, White CD, Caballero AR, O'Callaghan RJ, Hobden JA. Pseudomonas aeruginosa LasA protease and corneal infections. Curr Eye Res. 2001;22(4):266 -271.
27. Lin CT, Peterson-Jones SM. Antibiotic susceptibility of bacterial isolates from corneal ulcers of dogs in Taiwan. J Small Anim Pract. 2007;48(5):271-274.
28. Tolar EL, Hendrix DV, Rohrbach BW, Plummer CE, Brooks DE, Gelatt KN. Evaluation of clinical characteristics and bacterial isolates in dogs with bacterial keratitis: 97 cases (1993-2003). J Am Vet Med Assoc. 2006;228(1):80-85.
29. Ledbetter EC, Hendricks LM, Riis RC, Scarlett JM. In vitro fluoroquinolone susceptibility of Pseudomonas aeruginosa isolates from dogs with ulcerative keratitis. Am J Vet Res. 2007;68(6):638-642.
30. Zhu H, Thuruthyil SJ, Wilcox MD. Invasive strains of Pseudomonas aeruginosa are able to cause epithelial cell cytotoxicity that is dependent on bacterial cell density. Clin Experiment Ophthalmol. 2000;28(3):201-204.
31. Solberg CO, Hellum KB. Protection of phagocytosed bacteria against antimicrobial agents. Scand J Infect Dis Suppl. 1978;(14): 246-250.
32. Vaudaux P, Waldvogel FA. Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1979;16(6):743-749.
33. Tulkens PM. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis. 1991;10(2):100 -106.
34. Lee EJ, Truong TN, Mendoza MN, Fleiszig SM. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease response to therapeutics. Curr Eye Res. 2003;27(5):289 -299.
35. Cowell BA, Weissman BA, Yeung KK, et al. Phenotype of Pseudomonas aeruginosa isolates causing corneal infection between 1997 and 2000. Cornea. 2003;22(2):131-134.
36. Massimino S, Kearns RJ, Loos KM, et al. Effects of age and dietary β-carotene on immunological variables in dogs. J Vet Intern Med. 2003;17(6):835- 842.
37. Greeley EH, Kealy RD, Ballam JM, Lawler DF, Segre M. The influence of age on the canine immune system. Vet Immunol Immunopathol. 1996;55(1-3):1-10.
38. Greeley EH, Ballam JM, Harrison JM, Kealy RD, Lawler DF, Segre M. The influence of age and gender on the immune system: a longitudinal study in Labrador Retriever dogs. Vet Immuno Immunopathol. 2001;82(1-2):57-71.
39. Felsburg PJ. Overview of immune system development in the dog: comparison with humans. Hum Exp Toxicol. 2002;21(9-10):487-492.
40. Blount DG, Heaton PR, Pritchard DI. Changes to levels of DNA damage and apoptotic resistance in peripheral blood mononuclear cells and plasma antioxidant potential with age in Labrador Retriever dogs. J Nutr. 2004;134(8 Suppl):2120S-2123S.
41. Polignano A, Tortorella C, Venezia A, Jirillo E, Antonaci S. Ageassociated changes in neutrophil responsiveness in a human healthy elderly population. Cytobios. 1994;80(322):145-153.
42. Antonaci S, Jirillo E, Ventura MT, Garofalo AR, Bonomo L. Nonspecific immunity in aging: deficiency of monocyte and polymorphonuclear cell-mediated functions. Mech Ageing Dev. 1984; 24(3):357-375.
43. Kernacki KA, Barrett RP, McClellan SA, Hazlett LD. Aging and PMN response to P. aeruginosa infection. Invest Ophthalmol Vis Sci. 2000;41(10):3019-3025.
44. Bistner SI, Roberts SR, Anderson RP. Conjunctival bacteria: clinical appearances can be deceiving. Mod Vet Pract. 1969;50(13):45- 47.
45. Urban M, Wyman M, Rheins M, Marraro RV. Conjunctival flora of clinically normal dogs. J Am Vet Med Assoc. 1972;161(2):201-206.
46. McDonald PJ, Watson DJ. Microbial flora of normal canine conjunctivae. J Small Anim Pract. 1976;17(12):809-812.
47. Hacker DV, Jensen HE, Selby LA. A comparison of conjunctival culture techniques in the dog. J AmVet Med Assoc. 1979;15(2):223-225.
48. Gerding PA Jr., Cormany K, Weisiger R, Kakoma I. Survey and topographic distribution of bacterial and fungal microorganisms in eyes of clinically normal dogs. Canine Pract. 1993;18(2):34 -38.
49. Jones WG. A preliminary report of the flora in health and disease of the external ear and conjunctival sac of the dog. J Am Vet Med Assoc. 1955;127(944):442-443.
50. Peterson-Jones SM. Quantification of conjunctival sac bacteria in normal dogs and those suffering from keratoconjunctivitis sicca. Vet Comp Ophthalmol. 1997;7(1):29 -35.
51. Singer TR, Isenberg SJ, Apt L. Conjunctival anaerobic and aerobic bacterial flora in paediatric versus adult subjects. Br J Ophthalmol. 1988;72(6)448-451.
52. Fleiszig SM, Efron N. Microbial flora in eyes of current and former contract lens wearers. J Clin Microbiol. 1992;30(5):1156-1161.
53. Walker CD, Claoué CMP. Incidence of conjunctival colonization by bacteria capable of causing postoperative endophthalmitis. J R Soc Med. 1986;79(9):520 -521.
54. Stapleton F, Dart JK, Seal DV, Matheson M. Epidemiology of Pseudomonas aeruginosa keratitis in contact lens wearers. Epidemiol Infect. 1995;114(3):395- 402.
55. Kenchappa P, Sangwan VS, Ahmed N, et al. High-resolution genotyping of Pseudomonas aeruginosa strains linked to acute post cataract surgery endophthalmitis outbreaks in India. Ann Clin Microbiol Antimicrob. 2005;4(19):1- 8.
56. Prabha V, Singh N, Chopra P. Bacteriological evaluation of conjunctiva, contact lens storage cases, and solutions during contact lens wear. Indian J Pathol Microbiol. 2007;50(1)101-103.
57. Rajvanshi VS. Bacterial flora of the conjunctiva. J All India Ophthalmol Soc. 1968;16(1):24 -28.
58. Tomar VP, Sharma OP, Joshi K. Bacterial and fungal flora of normal conjunctiva. Ann Ophthalmol. 1971;3(6):669-671